Queensland researchers are hoping a novel immunotherapy for rheumatoid arthritis will ‘frame the discussion’ between dendritic cells and T-cells to dampen down the immune response. A phase 1 clinical trial of DEN-181 has opened in Brisbane at the Princess Alexandra Hospital to test the safety, tolerability and pharmacodynamics of the new agent in adults with ...
Novel immunotherapy trial for rheumatoid arthritis
By Mardi Chapman
16 Nov 2017